Neuland Laboratories Verschuldung / Eigenkapital
Was ist das Verschuldung / Eigenkapital von Neuland Laboratories?
Verschuldung / Eigenkapital von Neuland Laboratories Limited ist 0.73
Was ist die Definition von Verschuldung / Eigenkapital?
Die Verschuldung zu Eigenkapital ist ein Finanzverhältnis, das den relativen Anteil des Eigenkapitals und der Verschuldung angibt, die zur Finanzierung der Vermögenswerte eines Unternehmens verwendet werden.
The debt to equity ratio is generally calculated by dividing debt by equity. The D/E ratio is also known as risk, gearing or leverage. The two components are often taken from the firm's balance sheet or statement of financial position (so-called book value), but the ratio may also be calculated using market values for both, if the company's debt and equity are publicly traded, or using a combination of book value for debt and market value for equity financially. Preferred stock can be considered part of debt or equity. Attributing preferred shares to one or the other is partially a subjective decision but will also take into account the specific features of the preferred shares. When used to calculate a company's financial leverage, the debt usually includes only the long-term debt.
Verschuldung / Eigenkapital von Unternehmen in Health Care Sektor auf BSE im Vergleich zu Neuland Laboratories
Was macht Neuland Laboratories?
Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, antiemetic, central nervous system, fluoroquinolones, corticosteroids, antipsychotic, antibacterial and anti-parkinson, anti-ulcerants, and prostaglandins. It also provides custom manufacturing solutions, as well as peptide synthesis services. The company was founded in 1984 and is headquartered in Hyderabad, India.
Unternehmen mit verschuldung / eigenkapital ähnlich Neuland Laboratories
- Kinross Gold hat Verschuldung / Eigenkapital von 0.73
- Akme Star Housing Finance hat Verschuldung / Eigenkapital von 0.73
- Premier Inc hat Verschuldung / Eigenkapital von 0.73
- Helen of Troy Ltd hat Verschuldung / Eigenkapital von 0.73
- Skillcast plc hat Verschuldung / Eigenkapital von 0.73
- Irish Residential Properties REIT Plc hat Verschuldung / Eigenkapital von 0.73
- Neuland Laboratories hat Verschuldung / Eigenkapital von 0.73
- RevoluGROUP Canada hat Verschuldung / Eigenkapital von 0.73
- Nanjing Wondux Environmental Protection Technology hat Verschuldung / Eigenkapital von 0.73
- Century Communities Inc hat Verschuldung / Eigenkapital von 0.73
- Culp hat Verschuldung / Eigenkapital von 0.73
- Steel City Securities hat Verschuldung / Eigenkapital von 0.73
- Acadia Pharmaceuticals Inc hat Verschuldung / Eigenkapital von 0.73